Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 210 
Year : 2014  |  Volume : 20  |  Issue : 6  |  Page : 333-341

Transarterial therapy: An evolving treatment modality of hepatocellular carcinoma

1 College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
2 Department of Medical Imaging, Prince Sultan Military Medical City, Riyadh, Saudi Arabia
3 Department of Medical Imaging, King Abdulaziz Medical City, Riyadh, Saudi Arabia

Correspondence Address:
Khalid A Jazieh
Alfaisal University, P.O. Box 50927, Riyadh 11533
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1319-3767.145315

Rights and Permissions

Liver cancer is the fifth most common cancer in men, the seventh most common in women, and the third most common cause of death from cancer worldwide. Only 30-40% of liver cancer patients present early enough to undergo curative treatments such as surgery or liver transplantation. Local treatment with radiofrequency ablation or ethanol injection is often reserved for non-surgical candidates with early stages of disease. Transarterial embolization has become a widely accepted treatment for asymptomatic patients with unresectable lesions. This review discusses in details the three major forms of transarterial therapies: Bland embolization, chemoembolization, and radioembolization.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded783    
    Comments [Add]    
    Cited by others 2    

Recommend this journal